AlphaFold predicted structure
TGFBR2 · P37173

Mean pLDDT
81.0/ 100
Confident
567 residues
Confidence breakdown
- Very high(≥ 90)57%
- Confident(70–90)20%
- Low(50–70)5%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transforming growth factor beta receptor 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Arthrogryposis
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownClefting
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedCOVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEhlers Danlos syndrome with a likely monogenic cause
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownInfantile enterocolitis & monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPneumothorax - familial
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown+8 more panels — install the extension to see the full list inline on any page.
Loeys-Dietz syndrome
Loeys-Dietz syndrome 2
Marfan syndrome
familial thoracic aortic aneurysm and aortic dissection
Marfan syndrome type 2
esophageal cancer
neurodegenerative disease
colorectal cancer, hereditary nonpolyposis, type 6
cancer
breast carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
TGF-beta receptor type-2
Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways
TGFBR2 · P37173

Mean pLDDT
81.0/ 100
Confident
567 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0